PLEASANTON, Calif., April 13, 2011 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the first quarter of fiscal 2011 on Tuesday, May 3.
The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Tuesday, May 3, hosted by Gary F. Burbach, president and chief executive officer, and David V. Smith, executive vice president and chief financial officer.
The teleconference can be accessed by calling (719) 325-2417, passcode 2968035. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at http://phx.corporate-ir.net/phoenix.zhtml?p=iroleventDetails&c=95989&eventID=3951274 or http://www.thoratec.com.
A replay of the conference call will be available through Tuesday, May 10, via http://www.thoratec.com or by telephone at (719) 457-0820, passcode 2968035.
Thoratec is a world leader in therapies to address advanced-stage heart failure. The company’s products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 18,000 devices implanted in patients suffering from heart failure. Thoratec is headquartered in Pleasanton, California. For more information, visit the company’s web site at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation.
SOURCE Thoratec Corporation
